EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone

Shehla Akbar, Fazal Subhan, Aroosha Akbar, Faiza Habib, Naila Shahbaz, Ashfaq Ahmad, Abdul Wadood, Saad Salman iD

Nutrients · 2023

DOI: 10.3390/nu15112552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Shehla Akbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar 25000, Pakistan. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Neuralgia, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is evident that inflammation and metabolic syndrome instigated by diabetes mellitus can precipitate diabetes-induced neuropathy (DIN) and pain. In order to find an effective therapeutic method for diabetes-related problems, a multi-target-directed ligand model was used. 6-Hydroxyflavanone (6-HF) carrying anti-inflammatory and anti-neuropathic pain potential due to its quadruplicate mechanisms, targeting cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and opioid and GABA-A receptors was investigated. The anti-inflammatory potential of the test drug was confirmed utilizing in silico, in vitro, and in vivo tests. A molecular simulation approach was utilized to observe the interaction of 6-HF with the inflammatory enzyme COX-2 as well as opioid and GABA-A receptors. The same was confirmed via in vitro COX-2 and 5-LOX inhibitory assays. In vivo tests were performed to analyze the thermal anti-nociception in the hot-plate analgesiometer and anti-inflammatory action in the carrageenan-induced paw edema model in rodents. The potential anti-nociceptive effect of 6-HF was evaluated in the DIN model in rats. The Naloxone and Pentylenetetrazole (PTZ) antagonists were used to confirm the underlying mechanism of 6-HF. The molecular modeling studies revealed a favorable interaction of 6-HF with the identified protein molecules. In vitro inhibitory studies revealed that 6-HF inhibited the COX-2 and 5-LOX enzymes significantly. The 6-HF at dosages of 15, 30, and 60 mg/kg substantially reduced heat nociception in a hot plate analgesiometer as well as carrageenan-induced paw edema in rodent models. The authors discovered that 6-HF had anti-nociception properties in a streptozotocin-induced diabetic neuropathy model. According to the findings of this study, 6-HF was demonstrated to diminish inflammation caused by diabetes as well as its anti-nociception effect in DIN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesNeuralgiaDiabetes MellitusRatsAnimalsCarrageenanCyclooxygenase 2Analgesics, OpioidReceptors, GABA-AAnti-Inflammatory AgentsInflammationEdemaAnalgesics

Stichwörter der Autor:innen

6-hydroxyflavanonediabetes-induced neuropathyinflammation

Substanzen

CarrageenanCyclooxygenase 2Analgesics, OpioidReceptors, GABA-AAnti-Inflammatory AgentsAnalgesics

Autor:innen und Institutionen

  • Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar 25000, Pakistan.
  • North West Institute of Health Sciences, Peshawar 25000, Pakistan.
  • Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25000, Pakistan.
  • Department of Pharmacy, Sarhad University of Science and Technology, Peshawar 25000, Pakistan.
  • Department of Biochemistry, Shankar Abdul Wali Khan University, Mardan 23200, Pakistan.

ORCID-Profile: Saad Salman

Zitieren

APA

Akbar, S., Subhan, F., Akbar, A., Habib, F., Shahbaz, N., Ahmad, A., Wadood, A., & Salman, S. (2023). Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone. Nutrients. https://doi.org/10.3390/nu15112552

Vancouver

Akbar S, Subhan F, Akbar A, Habib F, Shahbaz N, Ahmad A, et al. Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone. Nutrients. 2023. doi:10.3390/nu15112552

BibTeX
@article{Akbar2023,
  author = {Akbar, Shehla and Subhan, Fazal and Akbar, Aroosha and Habib, Faiza and Shahbaz, Naila and Ahmad, Ashfaq and Wadood, Abdul and Salman, Saad},
  title = {Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15112552}
}
Kostenlos starten →